Page 3 - Lakes Bioscience News Today

PHARMACEUTICAL giant GlaxoSmithKline is preparing to start human trials of an HIV cure in a groundbreaking leap which could finally rid millions of…

A PHARMACEUTICAL manufacturing firm has signed an agreement to initiate the development of a world leading life sciences factory

Andy Beeforth, chief executive of Cumbria Community Foundation, talks the importance of getting young people into the great outdoors.

On Thursday the GSK Taskforce met to discuss where we have got to since the announcement in February that GSK would be pulling out of Ulverston and…

A LEGACY of hundreds of jobs and community investment is due to be left when one of Ulverston’s largest employers closes its site. Glaxosmithkline has agreed ‘concrete’ steps to support employment and development when its site closes as planned in 2025. The pharmaceuticals company has granted £500,000 in funding in initiatives to secure 238 jobs at other local jobs. It has also confirmed its support for Lakes BioScience, a new biomanufacturing plant, which could create new jobs i...

Important steps agreed to support long-term employment in Ulverston Artist’s impressions of Lakes BioScience’s biopharmaceuticals site in Ulverston Important steps have been agreed that will support long term-employment in Ulverston after one of the town’s biggest employers revealed it would be closing its site earlier this year. GlaxoSmithKline (GSK) revealed in February it would be closing its site in the town by 2025, with operations being transferred to German firm Sandoz. Durin...

THE MP has appealed to the Prime Minister calling on his support to secure plans for Lakes BioScience at the GSK Site in Ulverston. Simon Fell, MP for Barrow and Furness, has penned a letter to Prime Minister Boris Johnson appealing for his backing to secure the site for Lakes BioScience which he believes will be a win-win for the community. Earlier this month, GSK announced it would shutter their facilities in Ulverston by 2025 after 75 years of operation following the sale of their anti...

BARROW and Furness MP has urged the Prime Minister to support plans for the Lakes BioScience at the GSK Site in Ulverston.

Column by Barrow and Furness MP Simon Fell:

GSK in Ulverston Barrow MP Simon Fell has called a public meeting to discuss the future of the GSK site in Ulverston. Last week, the pharmaceuticals giant announced it is to close the cephalosporin division of its business as part of a $350 million sale to another pharmaceuticals firm, Novartis’ Sandoz. GSK confirmed that it will continue to produce the antibiotic Zinnat at the Ulverston site until 2025. An emergency taskforce meeting was convened by Mr Fell took place on Wednesday. Direct...